Partnerships between pharmaceutical companies, the broader scientific community, multilateral agencies, and governments are core to our success. These partnerships can range from the development of new medical products to supporting the clinical services needed to improve both individual and public health outcomes – and everything in between. Our flagship event at the 77th World Health Assembly will be an opportunity to hear perspectives from leading figures across this community about how these partnerships can go further to deliver meaningful impact for people and healthcare systems around the world.
